The FDA’s newly launched plausible mechanism framework may have been forged in the image of individualized therapies, but its principles are not confined to the bespoke, Teresa Buracchio, M.D., head of the FDA’s Office of Neuroscience, told Fierce.
Morbi et tellus imperdiet, aliquam nulla sed, dapibus erat. Aenean dapibus sem non purus venenatis vulputate. Donec accumsan eleifend blandit. Nullam auctor ligula
The FDA’s newly launched plausible mechanism framework may have been forged in the image of individualized therapies, but its principles are not confined to the bespoke, Teresa Buracchio, M.D., head of the FDA’s Office of Neuroscience, told Fierce.